Histopathological changes in the gastrointestinal tract due to medications: An update for the surgical pathologist (part ii of ii)

Giovanni De Petris, Sonia Gatius Caldero, Longwen Chen, Shu Yuan Xiao, Bal M. Dhungel, Amy J. Wendel Spizcka, Dora Lam-Himlin

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

In keeping with the stated goal of providing the surgical pathologist with tools to recognize abnormalities of the gastrointestinal (GI) tract due to drugs (AGIDS), in part II of this review we embark in a more organ-based description of AGIDS. Adequate space is given to the numerous adverse gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Pill esophagitis, esophagitis dissecans, proton pump inhibitors' effects, diaphragm disease, and the recently described effects of drugs such as olmesartan, mycophenolate, and of compounds such as yttrium-90 are highlighted among several others. The inclusion of drug effects in the differential diagnosis of "conventional" diseases (such as gastric antral vascular ectasia, graft-versus-host disease, ischemic colitis, acute colitis, collagenous enteritis, inflammatory bowel disease) is underscored to avoid sometimes significant diagnostic pitfalls. We reiterate the message of the necessary collaboration between pathologist and clinician in the recognition of these entities to provide the best patient care.

Original languageEnglish (US)
Pages (from-to)202-211
Number of pages10
JournalInternational Journal of Surgical Pathology
Volume22
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Gastrointestinal Tract
Esophagitis
Pharmaceutical Preparations
Gastric Antral Vascular Ectasia
Collagenous Colitis
Ischemic Colitis
Yttrium
Enteritis
Proton Pump Inhibitors
Graft vs Host Disease
Diaphragm
Inflammatory Bowel Diseases
Patient Care
Differential Diagnosis
Anti-Inflammatory Agents
Pathologists

Keywords

  • adverse gastrointestinal tract drug effect
  • diaphragm disease
  • mycophenolate
  • nonsteroidal anti-inflammatory drugs
  • olmesartan

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine
  • Surgery
  • Medicine(all)

Cite this

De Petris, G., Gatius Caldero, S., Chen, L., Xiao, S. Y., Dhungel, B. M., Wendel Spizcka, A. J., & Lam-Himlin, D. (2014). Histopathological changes in the gastrointestinal tract due to medications: An update for the surgical pathologist (part ii of ii). International Journal of Surgical Pathology, 22(3), 202-211. https://doi.org/10.1177/1066896913502230

Histopathological changes in the gastrointestinal tract due to medications : An update for the surgical pathologist (part ii of ii). / De Petris, Giovanni; Gatius Caldero, Sonia; Chen, Longwen; Xiao, Shu Yuan; Dhungel, Bal M.; Wendel Spizcka, Amy J.; Lam-Himlin, Dora.

In: International Journal of Surgical Pathology, Vol. 22, No. 3, 2014, p. 202-211.

Research output: Contribution to journalReview article

De Petris, Giovanni ; Gatius Caldero, Sonia ; Chen, Longwen ; Xiao, Shu Yuan ; Dhungel, Bal M. ; Wendel Spizcka, Amy J. ; Lam-Himlin, Dora. / Histopathological changes in the gastrointestinal tract due to medications : An update for the surgical pathologist (part ii of ii). In: International Journal of Surgical Pathology. 2014 ; Vol. 22, No. 3. pp. 202-211.
@article{42c5e0031d7b4291a5795889d5c4326e,
title = "Histopathological changes in the gastrointestinal tract due to medications: An update for the surgical pathologist (part ii of ii)",
abstract = "In keeping with the stated goal of providing the surgical pathologist with tools to recognize abnormalities of the gastrointestinal (GI) tract due to drugs (AGIDS), in part II of this review we embark in a more organ-based description of AGIDS. Adequate space is given to the numerous adverse gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Pill esophagitis, esophagitis dissecans, proton pump inhibitors' effects, diaphragm disease, and the recently described effects of drugs such as olmesartan, mycophenolate, and of compounds such as yttrium-90 are highlighted among several others. The inclusion of drug effects in the differential diagnosis of {"}conventional{"} diseases (such as gastric antral vascular ectasia, graft-versus-host disease, ischemic colitis, acute colitis, collagenous enteritis, inflammatory bowel disease) is underscored to avoid sometimes significant diagnostic pitfalls. We reiterate the message of the necessary collaboration between pathologist and clinician in the recognition of these entities to provide the best patient care.",
keywords = "adverse gastrointestinal tract drug effect, diaphragm disease, mycophenolate, nonsteroidal anti-inflammatory drugs, olmesartan",
author = "{De Petris}, Giovanni and {Gatius Caldero}, Sonia and Longwen Chen and Xiao, {Shu Yuan} and Dhungel, {Bal M.} and {Wendel Spizcka}, {Amy J.} and Dora Lam-Himlin",
year = "2014",
doi = "10.1177/1066896913502230",
language = "English (US)",
volume = "22",
pages = "202--211",
journal = "International Journal of Surgical Pathology",
issn = "1066-8969",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Histopathological changes in the gastrointestinal tract due to medications

T2 - An update for the surgical pathologist (part ii of ii)

AU - De Petris, Giovanni

AU - Gatius Caldero, Sonia

AU - Chen, Longwen

AU - Xiao, Shu Yuan

AU - Dhungel, Bal M.

AU - Wendel Spizcka, Amy J.

AU - Lam-Himlin, Dora

PY - 2014

Y1 - 2014

N2 - In keeping with the stated goal of providing the surgical pathologist with tools to recognize abnormalities of the gastrointestinal (GI) tract due to drugs (AGIDS), in part II of this review we embark in a more organ-based description of AGIDS. Adequate space is given to the numerous adverse gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Pill esophagitis, esophagitis dissecans, proton pump inhibitors' effects, diaphragm disease, and the recently described effects of drugs such as olmesartan, mycophenolate, and of compounds such as yttrium-90 are highlighted among several others. The inclusion of drug effects in the differential diagnosis of "conventional" diseases (such as gastric antral vascular ectasia, graft-versus-host disease, ischemic colitis, acute colitis, collagenous enteritis, inflammatory bowel disease) is underscored to avoid sometimes significant diagnostic pitfalls. We reiterate the message of the necessary collaboration between pathologist and clinician in the recognition of these entities to provide the best patient care.

AB - In keeping with the stated goal of providing the surgical pathologist with tools to recognize abnormalities of the gastrointestinal (GI) tract due to drugs (AGIDS), in part II of this review we embark in a more organ-based description of AGIDS. Adequate space is given to the numerous adverse gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Pill esophagitis, esophagitis dissecans, proton pump inhibitors' effects, diaphragm disease, and the recently described effects of drugs such as olmesartan, mycophenolate, and of compounds such as yttrium-90 are highlighted among several others. The inclusion of drug effects in the differential diagnosis of "conventional" diseases (such as gastric antral vascular ectasia, graft-versus-host disease, ischemic colitis, acute colitis, collagenous enteritis, inflammatory bowel disease) is underscored to avoid sometimes significant diagnostic pitfalls. We reiterate the message of the necessary collaboration between pathologist and clinician in the recognition of these entities to provide the best patient care.

KW - adverse gastrointestinal tract drug effect

KW - diaphragm disease

KW - mycophenolate

KW - nonsteroidal anti-inflammatory drugs

KW - olmesartan

UR - http://www.scopus.com/inward/record.url?scp=84899506382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899506382&partnerID=8YFLogxK

U2 - 10.1177/1066896913502230

DO - 10.1177/1066896913502230

M3 - Review article

C2 - 24021900

AN - SCOPUS:84899506382

VL - 22

SP - 202

EP - 211

JO - International Journal of Surgical Pathology

JF - International Journal of Surgical Pathology

SN - 1066-8969

IS - 3

ER -